{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:15:15Z","timestamp":1791753315199,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2007,4,23]],"date-time":"2007-04-23T00:00:00Z","timestamp":1177286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,4,23]],"date-time":"2007-04-23T00:00:00Z","timestamp":1177286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1038\/sj.bmt.1705650","type":"journal-article","created":{"date-parts":[[2007,4,23]],"date-time":"2007-04-23T11:08:14Z","timestamp":1177326494000},"page":"751-757","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":293,"title":["Long term disease-free survival in acute leukemia patients recovering with increased \u03b3\u03b4 T cells after partially mismatched related donor bone marrow transplantation"],"prefix":"10.1038","volume":"39","author":[{"given":"K T","family":"Godder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P J","family":"Henslee-Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B S","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K-Y","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Abhyankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L S","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,4,23]]},"reference":[{"key":"BF1705650_CR1","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1182\/blood.V86.10.3987.bloodjournal86103987","volume":"86","author":"MJ Hessner","year":"1995","unstructured":"Hessner MJ, Endean DJ, Casper JT, Horowitz MM, Keever-Taylor CA, Roth M et al. Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia. Blood 1995; 86: 3987\u20133996.","journal-title":"Blood"},{"key":"BF1705650_CR2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555\u2013562.","journal-title":"Blood"},{"key":"BF1705650_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-2141.1988.tb07628.x","volume":"69","author":"JF Apperley","year":"1988","unstructured":"Apperley JF, Mauro FR, Goldman JM, Gregory W, Arthur CK, Hows J et al. Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect. Br J Haematol 1988; 69: 239\u2013245.","journal-title":"Br J Haematol"},{"key":"BF1705650_CR4","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1182\/blood.V98.12.3192","volume":"98","author":"VT Ho","year":"2001","unstructured":"Ho VT, Soiffer RJ . The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 2001; 98: 3192\u20133204.","journal-title":"Blood"},{"key":"BF1705650_CR5","doi-asserted-by":"publisher","first-page":"806","DOI":"10.7326\/0003-4819-108-6-806","volume":"108","author":"JM Goldman","year":"1988","unstructured":"Goldman JM, Gale RP, Horowitz MM, Biggs JC, Champlin RE, Gluckman E et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med 1988; 108: 806\u2013814.","journal-title":"Ann Intern Med"},{"key":"BF1705650_CR6","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041\u20132050.","journal-title":"Blood"},{"key":"BF1705650_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","volume":"15","author":"RH Collins Jr","year":"1997","unstructured":"Collins Jr RH, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433\u2013444.","journal-title":"J Clin Oncol"},{"key":"BF1705650_CR8","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood.V82.8.2273.2273","volume":"82","author":"JH Antin","year":"1993","unstructured":"Antin JH . Graft-versus-leukemia: no longer an epiphenomenon. Blood 1993; 82: 2273\u20132277.","journal-title":"Blood"},{"key":"BF1705650_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1053\/bbmt.1999.v5.pm10465105","volume":"5","author":"DL Porter","year":"1999","unstructured":"Porter DL, Collins Jr RH, Shpilberg O, Drobyski WR, Connors JM, Sproles A et al. Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions. Biol Blood Marrow Transplant 1999; 5: 253\u2013261.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705650_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev.med.49.1.329","volume":"49","author":"F Dazzi","year":"1998","unstructured":"Dazzi F, Goldman JM . Adoptive immunotherapy following allogeneic bone marrow transplantation. Annu Rev Med 1998; 49: 329\u2013340.","journal-title":"Annu Rev Med"},{"key":"BF1705650_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1046\/j.1365-2141.1998.00830.x","volume":"102","author":"F Locatelli","year":"1998","unstructured":"Locatelli F . The role of repeat transplantation of haemopoietic stem cells and adoptive immunotherapy in treatment of leukaemia relapsing following allogeneic transplantation. Br J Haematol 1998; 102: 633\u2013638.","journal-title":"Br J Haematol"},{"key":"BF1705650_CR12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1046\/j.1365-2141.1996.d01-1713.x","volume":"93","author":"AJ Barrett","year":"1996","unstructured":"Barrett AJ, Malkovska V . Graft-versus-leukaemia: understanding and using the alloimmune response to treat haematological malignancies. Br J Haematol 1996; 93: 754\u2013761.","journal-title":"Br J Haematol"},{"key":"BF1705650_CR13","first-page":"61","volume":"1","author":"RL Truitt","year":"1995","unstructured":"Truitt RL, Johnson BD . Principles of graft-vs-leukemia reactivity. Biol Blood Marrow Transplant 1995; 1: 61\u201368.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705650_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev.med.50.1.369","volume":"50","author":"DL Porter","year":"1999","unstructured":"Porter DL, Antin JH . The graft-versus-leukemia effects of allogeneic cell therapy. Annu Rev Med 1999; 50: 369\u2013386.","journal-title":"Annu Rev Med"},{"key":"BF1705650_CR15","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood.V73.8.2077.2077","volume":"73","author":"A Bensussan","year":"1989","unstructured":"Bensussan A, Lagabrielle J, Degos L . TCR \u03b3\u03b4 bearing lymphocyte clones with lymphokine activated killer activity against autologous leukemic cells. Blood 1989; 73: 2077\u20132080.","journal-title":"Blood"},{"key":"BF1705650_CR16","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood.V73.6.1720.1720","volume":"73","author":"KM Sullivan","year":"1989","unstructured":"Sullivan KM, Weiden PL, Storb R, Witherspoon RP, Fefer A, Fisher L et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989; 73: 1720\u20131728.","journal-title":"Blood"},{"key":"BF1705650_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00007890-198708000-00016","volume":"44","author":"T Ghayur","year":"1987","unstructured":"Ghayur T, Seemayer TA, Lapp WS . Kinetics of natural killer cell cytotoxicity during graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity and development of histopathological alterations. Transplantation 1987; 44: 254.","journal-title":"Transplantation"},{"key":"BF1705650_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00001622-199703000-00006","volume":"9","author":"HJ Kolb","year":"1997","unstructured":"Kolb HJ, Holler E . Adoptive immunotherapy with donor lymphocyte transfusions. Curr Opin Oncol 1997; 9: 139\u2013145.","journal-title":"Curr Opin Oncol"},{"key":"BF1705650_CR19","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood.V88.7.2450.bloodjournal8872450","volume":"88","author":"J Molldrem","year":"1996","unstructured":"Molldrem J, Dermime S, Parker K, Jiang YZ, Mavroudis D, Hensel N et al. Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood 1996; 88: 2450\u20132457.","journal-title":"Blood"},{"key":"BF1705650_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1053\/bbmt.1999.v5.pm10392959","volume":"5","author":"MR Pelot","year":"1999","unstructured":"Pelot MR, Pearson DA, Swenson K, Zhao G, Sachs J, Yang YG et al. Lymphohematopoietic graft-vs-host reactions can be induced without graft-vs-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen. Biol Blood Marrow Transplant 1999; 5: 133\u2013143.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705650_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00007890-199307000-00021","volume":"56","author":"JL Rhoades","year":"1993","unstructured":"Rhoades JL, Cibull ML, Thompson JS, Henslee-Downey PJ, Jennings CD, Sinn HP et al. Role of natural killer cells in the pathogenesis of human acute graft versus host disease. Transplantation 1993; 56: 113\u2013120.","journal-title":"Transplantation"},{"key":"BF1705650_CR22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/sj.bmt.1703223","volume":"28","author":"S Slavin","year":"2001","unstructured":"Slavin S, Ackerstein A, Morecki S, Gelfand Y, Cividalli G . Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes. Bone Marrow Transplant 2001; 28: 795\u2013798.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705650_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1126\/science.1063916","volume":"294","author":"M Girardi","year":"2001","unstructured":"Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R et al. Regulation of cutaneous malignancy by gammadelta T cells. Science 2001; 294: 605\u2013609.","journal-title":"Science"},{"key":"BF1705650_CR24","first-page":"4014","volume":"53","author":"MJ Kaminski","year":"1993","unstructured":"Kaminski MJ, Cruz Jr PD, Bergstresser PR, Takashima A . Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells. Cancer Res 1993; 53: 4014\u20134019.","journal-title":"Cancer Res"},{"key":"BF1705650_CR25","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.1073\/pnas.96.12.6879","volume":"96","author":"V Groh","year":"1999","unstructured":"Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Thomas S . Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA 1999; 96: 6879\u20136884.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1705650_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.285.5428.727","volume":"285","author":"S Bauer","year":"1999","unstructured":"Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285: 727\u2013729.","journal-title":"Science"},{"key":"BF1705650_CR27","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1126\/science.279.5357.1737","volume":"279","author":"V Groh","year":"1998","unstructured":"Groh V, Steinle A, Bauer S, Spies T . Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 1998; 279: 1737\u20131740.","journal-title":"Science"},{"key":"BF1705650_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0952-7915(97)80159-8","volume":"9","author":"R Boismenu","year":"1997","unstructured":"Boismenu R, Havran WL . An innate view of gamma delta T cells. Curr Opin Immunol 1997; 9: 57\u201363.","journal-title":"Curr Opin Immunol"},{"key":"BF1705650_CR29","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1089\/scd.1.1996.5.503","volume":"5","author":"LS Lamb Jr","year":"1996","unstructured":"Lamb Jr LS, Henslee-Downey PJ, Parrish RS, Godder K, Thompson J, Lee C et al. Increased frequency of TCR gamma delta+ T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation for leukemia. J Hematother 1996; 5: 503\u2013509.","journal-title":"J Hematother"},{"key":"BF1705650_CR30","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1182\/blood.V89.10.3864","volume":"89","author":"PJ Henslee-Downey","year":"1997","unstructured":"Henslee-Downey PJ, Abhyankar SH, Parrish RS, Pati AR, Godder KT, Neglia WJ et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood 1997; 89: 3864\u20133872.","journal-title":"Blood"},{"key":"BF1705650_CR31","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1200\/JCO.2000.18.9.1856","volume":"18","author":"KT Godder","year":"2000","unstructured":"Godder KT, Hazlett LJ, Abhyankar SH, Chiang KY, Christiansen NP, Bridges KD et al. Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: younger donors and absence of peripheral blasts improve outcome. J Clin Oncol 2000; 18: 1856\u20131866.","journal-title":"J Clin Oncol"},{"key":"BF1705650_CR32","first-page":"523","volume":"389","author":"C Lee","year":"1994","unstructured":"Lee C, Brouillette M, Lamb L, Pati A, Brown S, Thompson J et al. Use of a closed system for V alpha beta-positive T cell depletion of marrow for use in partially mismatched related donor (PMRD) transplantation. Prog Clin Biol Res 1994; 389: 523\u2013532.","journal-title":"Prog Clin Biol Res"},{"key":"BF1705650_CR33","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/sj.bmt.1704391","volume":"33","author":"J Mehta","year":"2004","unstructured":"Mehta J, Singhal S, Gee AP, Chiang KY, Godder K, Rhee Fv et al. Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients. Bone Marrow Transplant 2004; 33: 389\u2013396.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705650_CR34","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"J Gray","year":"1988","unstructured":"Gray J . A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141\u20131154.","journal-title":"Ann Stat"},{"key":"BF1705650_CR35","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood.V87.10.4463.bloodjournal87104463","volume":"87","author":"BR Blazar","year":"1996","unstructured":"Blazar BR, Taylor PA, Bluestone JA, Vallera DA . Murine gamma\/delta-expressing T cells affect alloengraftment via the recognition of nonclassical major histocompatibility complex class Ib antigens. Blood 1996; 87: 4463\u20134472.","journal-title":"Blood"},{"key":"BF1705650_CR36","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/sj.bmt.1700807","volume":"19","author":"Y Kawanishi","year":"1997","unstructured":"Kawanishi Y, Passweg J, Drobyski WR, Rowlings P, Cook-Craig A, Casper J et al. Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation. Bone Marrow Transplant 1997; 19: 1069\u20131077.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705650_CR37","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.151.9.4465","volume":"151","author":"M Bigby","year":"1993","unstructured":"Bigby M, Markowitz JS, Bleicher PA, Grusby MJ, Simha S, Siebrecht M et al. Most gamma delta T cells develop normally in the absence of MHC class II molecules. J Immunol 1993; 151: 4465\u20134475.","journal-title":"J Immunol"},{"key":"BF1705650_CR38","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/sj.bmt.1702830","volume":"27","author":"LS Lamb Jr","year":"2001","unstructured":"Lamb Jr LS, Musk P, Ye Z, van Rhee F, Geier SS, Tong JJ et al. Human gammadelta(+) T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response. Bone Marrow Transplant 2001; 27: 601\u2013606.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705650_CR39","first-page":"205","volume":"7","author":"J Norton","year":"1991","unstructured":"Norton J, al-Saffar N, Sloane JP . An immunohistological study of gamma\/delta lymphocytes in human cutaneous graft-versus-host disease. Bone Marrow Transplant 1991; 7: 205\u2013208.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705650_CR40","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/bbmt.1999.v5.pm10465102","volume":"5","author":"WR Drobyski","year":"1999","unstructured":"Drobyski WR, Majewski D, Hanson G . Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs-host disease. Biol Blood Marrow Transplant 1999; 5: 222\u2013230.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705650_CR41","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.4049\/jimmunol.165.3.1634","volume":"165","author":"WR Drobyski","year":"2000","unstructured":"Drobyski WR, Vodanovic-Jankovic S, Klein J . Adoptively transferred gamma delta T cells indirectly regulate murine graft-versus-host reactivity following donor leukocyte infusion therapy in mice. J Immunol 2000; 165: 1634\u20131640.","journal-title":"J Immunol"},{"key":"BF1705650_CR42","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.4049\/jimmunol.155.9.4189","volume":"155","author":"CA Ellison","year":"1995","unstructured":"Ellison CA, MacDonald GC, Rector ES, Gartner JG . Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality. J Immunol 1995; 155: 4189\u20134198.","journal-title":"J Immunol"},{"key":"BF1705650_CR43","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/00002371-200009000-00004","volume":"23","author":"KE Schilbach","year":"2000","unstructured":"Schilbach KE, Geiselhart A, Wessels J, TNiethammer D, Handgretingee R . Human gammadelta T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells. J Immunother 2000; 23: 536\u2013548.","journal-title":"J Immunother"},{"key":"BF1705650_CR44","first-page":"243","volume":"17","author":"ME Cela","year":"1996","unstructured":"Cela ME, Holladay MS, Rooney CM, Richardson S, Alexander B, Krance RA et al. Gamma delta T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors. Bone Marrow Transplant 1996; 17: 243\u2013247.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705650_CR45","first-page":"741","volume":"14","author":"M Yabe","year":"1994","unstructured":"Yabe M, Yabe H, Hattori K, Hinohara T, Morimoto T, Kato S et al. Transition of T cell receptor gamma\/delta expressing double negative (CD4-\/CD8-) lymphocytes after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 741\u2013746.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705650_CR46","first-page":"249","volume":"10","author":"M Viale","year":"1992","unstructured":"Viale M, Ferrini S, Bacigalupo A . TCR gamma\/delta positive lymphocytes after allogeneic bone marrow transplantation. Bone Marrow Transplant 1992; 10: 249\u2013253.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705650_CR47","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/eji.1830260223","volume":"26","author":"S Tsuji","year":"1996","unstructured":"Tsuji S, Char D, Bucy RP, Simonsen M, Chen CH, Cooper MD . Gamma delta T cells are secondary participants in acute graft-versus-host reactions initiated by CD4+ alpha beta T cells. Eur J Immunol 1996; 26: 420\u2013427.","journal-title":"Eur J Immunol"},{"key":"BF1705650_CR48","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1182\/blood-2002-12-3665","volume":"102","author":"M Wilhelm","year":"2003","unstructured":"Wilhelm M, Kunzmann V, Eckstein S, Reimer P, Weissinger F, Ruediger T et al. Gammadelta T cells for immune therapy of patients with lymphoid malignancies. Blood 2003; 102: 200\u2013206.","journal-title":"Blood"},{"key":"BF1705650_CR49","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1007\/s00262-005-0094-6","volume":"55","author":"P Meeh","year":"2006","unstructured":"Meeh P, King KM, O'Brien R, Muga S, Buckhalts P, Neuberg R et al. Characterization of the \u03b3\u03b4 T cell response to acute leukemia. Cancer Immunol Immunother 2006; 55: 1072\u20131080.","journal-title":"Cancer Immunol Immunother"},{"key":"BF1705650_CR50","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.4049\/jimmunol.161.3.1558","volume":"161","author":"B Li","year":"1998","unstructured":"Li B, Bassiri H, Rossman MD, Kramer P, Eyuboglu AF, Torres M et al. Involvement of the Fas\/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis. J Immunol 1998; 161: 1558\u20131567.","journal-title":"J Immunol"},{"key":"BF1705650_CR51","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1046\/j.1523-1747.2003.12141.x","volume":"120","author":"K Argentati","year":"2003","unstructured":"Argentati K, Re F, Serresi S, Tucci MG, Bartozzi B, Bernardini G et al. Reduced number and impaired function of circulating gamma delta T cells in patients with cutaneous primary melanoma. J Invest Dermatol 2003; 120: 829\u2013834.","journal-title":"J Invest Dermatol"},{"key":"BF1705650_CR52","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.4049\/jimmunol.154.8.3704","volume":"154","author":"M Ferrarini","year":"1995","unstructured":"Ferrarini M, Heltai S, Toninelli E, Sabbadini MG, Pellicciari C, Manfredi AA . Daudi lymphoma killing triggers the programmed death of cytotoxic V gamma 9\/V delta 2T lymphocytes. J Immunol 1995; 154: 3704\u20133712.","journal-title":"J Immunol"},{"key":"BF1705650_CR53","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V96.2.384","volume":"96","author":"V Kunzmann","year":"2000","unstructured":"Kunzmann V, Bauer E, Feurle J, Weissinger F, Tony HP, Wilhelm M . Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000; 96: 384\u2013392.","journal-title":"Blood"},{"key":"BF1705650_CR54","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbmt.2004.11.015","volume":"11","author":"LS Lamb Jr","year":"2005","unstructured":"Lamb Jr LS, Lopez RD . gammadelta T cells: a new frontier for immunotherapy? Biol Blood Marrow Transplant 2005; 11: 161\u2013168.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705650_CR55","doi-asserted-by":"publisher","first-page":"12510","DOI":"10.1073\/pnas.95.21.12510","volume":"95","author":"A Steinle","year":"1998","unstructured":"Steinle A, Groh V, Spies T . Diversification, expression, and gamma delta T cell recognition of evolutionarily distant members of the MIC family of major histocompatibility complex class I-related molecules. ProcNatl Acad Sci USA 1998; 95: 12510\u201312515.","journal-title":"ProcNatl Acad Sci USA"},{"key":"BF1705650_CR56","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/sj.bmt.1703043","volume":"27","author":"H Dolstra","year":"2001","unstructured":"Dolstra H, Fredrix H, van der Meer A, de Witte T, Figdor C, van de Wiel-van et al. TCR gamma delta cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cells. Bone Marrow Transplant 2001; 27: 1087\u20131093.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705650_CR57","first-page":"863","volume":"9","author":"M Duval","year":"1995","unstructured":"Duval M, Yotnda P, Bensussan A, Oudhiri N, Guidal C, Rohrlich P et al. Potential antileukemic effect of gamma delta T cells in acute lymphoblastic leukemia. Leukemia 1995; 9: 863\u2013868.","journal-title":"Leukemia"},{"key":"BF1705650_CR58","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1182\/blood.V73.5.1340.1340","volume":"73","author":"CA Keever","year":"1989","unstructured":"Keever CA, Small TN, Flomenberg N, Heller G, Pekle K, Black P et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 1989; 73: 1340\u20131350.","journal-title":"Blood"},{"key":"BF1705650_CR59","first-page":"7","volume":"11","author":"AB Foot","year":"1993","unstructured":"Foot AB, Potter MN, Donaldson C, Cornish JM, Wallington TB, Oakhill A et al. Immune reconstitution after BMT in children. Bone Marrow Transplant 1993; 11: 7\u201313.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705650_CR60","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood.V88.3.1089.1089","volume":"88","author":"H Kook","year":"1996","unstructured":"Kook H, Goldman F, Giller R, Goeken N, Peters C, Comito M et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood 1996; 88: 1089\u20131097.","journal-title":"Blood"},{"key":"BF1705650_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/0032472031000141295","volume":"1","author":"LSHL Lamb","year":"1999","unstructured":"Lamb LS HL, Gee A, Hazlett L, Musk P, Parrish R, O'Hanlon T et al. Influence of T cell depletion method on circulating \u03b3\u03b4+ T cell reconstitution and potential role in the graft-versus-leukemia effect. Cytotherapy 1999; 1: 7\u201319.","journal-title":"Cytotherapy"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705650","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T15:25:49Z","timestamp":1707837949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,23]]},"references-count":61,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["BF1705650"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705650","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,23]]},"assertion":[{"value":"22 March 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}